Because male breast cancer is rare, the Food and Drug Administration (FDA) doesn't have very good clinical trial data on treatments. "We tend to treat men the same way we treat women," says Tatiana M. Prowell, MD, a medical oncologist and breast cancer scientific lead at FDA's Office of Hematology & Oncology Products.
June is Men's Health Month. To learn about treatments for male breast cancer, read the Consumer Update.
FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information" as the source. FDA values feedback on its consumer health information. Send questions, comments or story ideas to: [email protected].
For rates and information on advertising, call Mike McCurdy at 877-634-9180. Or email at [email protected] We have over 7,000 journalists as subscribers.